I randomiserade, placebokontrollerade kliniska studier ökade inte filgrastim incidensen av biverkningar i samband med cytotoxisk kemoterapi. ###>In randomised, placebo-controlled clinical studies, filgrastim did not increase the incidence of undesirable effects associated with cytotoxic chemotherapy.